GlassScriptPhysician profile
Daniel W Nelson
NPI 1750812491
$49,898.12
in general payments reported to CMS, 2019-2025
9 companies · $13K in 2025
The $13K reported for 2025 was more than what 83% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $984 · 2023: $18K · 2024: $19K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $20K · Grant: $15K · Food and Beverage: $13K · Education: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $20,391.41 |
| Grant | $14,583.33 |
| Food and Beverage | $13,287.04 |
| Education | $652.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17,959.65 | 2023-2025 | Ensite Precision, Ensite, Agilis |
| Medtronic, INC. | $15,540.54 | 2023-2025 | Micra, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $9,341.92 | 2022-2025 | General - Ep, Versacross Access Solution, Watchman Flx |
| Medical Device Business Services, INC. | $3,016.46 | 2024 | Carto 3 |
| Biotronik INC. | $1,925.54 | 2024-2025 | Pamira, Amvia Edge, Solia |
| Biosense Webster, INC. | $1,731.51 | 2025 | Carto 3, Visitag Surpoint External Processing Unit, Nuvision Ice Catheter |
| Edwards Lifesciences Corporation | $205.62 | 2025 | Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.16 | 2024 | Lifevest |
| Abiomed | $79.72 | 2023 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.